Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CRSPCRSP
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CRISPR THERAPEUTICS AG

GEODE CAPITAL MANAGEMENT, LLC holds 2.5M shares of CRSP (CRISPR THERAPEUTICS AG), worth $136.9M as of 2026-Q2. The position was increased (+5.6% shares). CRSP represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$136.9M

Current Shares

2.5M

Total Value Change

+$89.5M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+5.6%
$136.9M0.0%$54.54
32
2026-Q1
Increased
2.4M
+5.7%
$113.1M0.0%$58.06
32
2025-Q4
Increased
2.2M
+5.0%
$118M0.0%$53.19
32
2025-Q3
Increased
2.1M
+3.3%
$138.8M0.0%$63.77
31
2025-Q2
Increased
2.1M
+98.1%
$100.8M0.0%$47.49
48
2025-Q1
Increased
1M
+4.5%
$35.6M0.0%$36.99
30
2024-Q4
Decreased
1M
-0.7%
$39.4M0.0%$38.65
0
2024-Q3
Increased
1M
+3.6%
$47.4M0.0%$47.32
30

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used